Results for tag: "Argatroban"

Argatroban is a hematological drug used to treat and prevent blood clots in patients with certain conditions. It is a direct thrombin inhibitor, meaning it works by blocking the action of thrombin, an enzyme involved in the clotting process. It is used to treat and prevent thrombosis in patients with heparin-induced thrombocytopenia (HIT), a condition in which the body produces antibodies against heparin, a commonly used anticoagulant. It is also used to treat and prevent thrombosis in patients with other conditions, such as atrial fibrillation and deep vein thrombosis. Argatroban is available in both intravenous and subcutaneous formulations. It is typically administered as an intravenous infusion over a period of several hours, or as a subcutaneous injection. The drug is available in a variety of strengths and formulations, and is typically prescribed by a doctor. The Argatroban market is highly competitive, with several companies offering the drug. Some of the major players in the market include Pfizer, Sanofi, Bristol-Myers Squibb, and Bayer. Show Less Read more